ARTICLE | Finance
Progenics
May 30, 2000 7:00 AM UTC
Progenics (PGNX) slid $23.063 (70 percent) to $10 on 7 million shares on Friday after announcing that the Eastern Cooperative Oncology Group was dropping out of the company's Phase III trial of its ...